Drug intelligence / Profile preview

Geo Relief

Development stage: Preclinical
Lead developer: PlantEXT
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Topical

Overview

Geo Relief is a topical cream formulation developed by PlantEXT, combining cannabidiol (CBD) and terpenes. It is designed as an all-natural medical product to alleviate pain, specifically targeting conditions such as arthritis and migraine, without conventional pharmaceutical drug intervention. The formulation leverages the synergistic anti-inflammatory and analgesic properties of cannabinoids and terpenes to provide localized pain relief.

Brand names: Geo Relief

Beyond the preview

Go deeper on Geo Relief.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Geo Relief.

Explore the full profile